The development of a rat in vitro model of spinal cord injury demonstrating the additive effects of rho and ROCK inhibitors on neurite outgrowth and myelination

GLIA

Volumn 60, Issue 3, 2012, Pages 441-456

  Boomkamp, Stephanie D ^a   Riehle, Mathis O ^a   Wood, Jenifer ^a   Olson, Michael F ^a   Barnett, Susan C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Astrocyte reactivity; Myelinating cultures; Neurite outgrowth; Rho and ROCK; Spinal cord injury

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; EXOENZYME C3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL CULTURE; CELL INFILTRATION; CONTROLLED STUDY; DEMYELINATION; DRUG POTENTIATION; IN VITRO STUDY; MICROGLIA; MYELINATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; RANVIER NODE; RAT; REMYELINIZATION; SPINAL CORD; SPINAL CORD INJURY;

AMIDES; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD11B; ASTROCYTES; CELLS, CULTURED; COMPLEMENT C3; DEMYELINATING DISEASES; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; FATTY ACID-BINDING PROTEINS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; GTPASE-ACTIVATING PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; NERVE TISSUE PROTEINS; NEURITES; NEURONS; O ANTIGENS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; SPINAL CORD; TIME FACTORS;

EID: 84856210692     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22278     Document Type: Article

References (61)

1. Abe K, Misawa M. 2003. Astrocyte stellation induced by Rho kinase inhibitors in culture. Brain Res Dev Brain Res. 143: 99-104.
2. Abnet K, Fawcett JW, Dunnett SB. 1991. Interactions between meningeal cells and astrocytes in vivo and in vitro. Dev Brain Res 53: 187-196.
3. Akbik F, Cafferty WBJ, Strittmatter SM. 2011 Myelin assoicated inhibitors:A link between injury-induced and experience dependent plasticity. Exp Neurol In press.
4. Asher RA, Morgenstern DA, Fidler PS, Adcock KH, Oohira A, Braistead JE, Levine JM, Margolis RU, Rogers JH, Fawcett JW. 2000. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 20: 2427-2438.
5. Baptiste DC, Tighe A, Fehlings MG. 2009. Spinal cord injury and neural repair: Focus on neuroregenerative approaches for spinal cord injury. Expert Opin Invest Drugs 18: 663-673.
6. Barnett SC, Riddell JS. 2007. Olfactory ensheathing cell transplantation as a strategy for spinal cord repair-What can it achieve? Nat Clin Pract Neurol 3: 152-161.
7. Bartholdi D, Schwab ME. 1997. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: An in situ hybridization study. Eur J Neurosci 9: 1422-1438.
8. Beattie MS, Hermann GE, Rogers RC, Bresnahan JC. 2002. Cell death in models of spinal cord injury. Prog Brain Res 137: 37-47.
9. Bottenstein JE, GH Sato 1979. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76: 514-517.
10. Bradbury EJ, Carter LM. 2011. Manipulating the glial scar: Chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 84: 3006-316.
11. Bunge RP, Puckett WR, Hiester ED. 1997. Observations on the pathology of several types of human spinal cord injury, with emphasis on the astrocyte response to penetrating injuries. Adv Neurol 72: 305-315.
12. Chan CC, Khodarahmi K, Liu J, Sutherland D, Oschipok LW, Steeves JD, Tetzlaff W. 2005. Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury. Exp Neurol 196: 352-364.
13. Chan CC, Wong AK, Liu J, Steeves JD, Tetzlaff W. 2007. ROCK inhibition with Y27632 activates astrocytes and increases their expression of neurite growth-inhibitory chondroitin sulfate proteoglycans. Glia 55: 369-384.
14. Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. 2001. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 3: 339-345.
15. Croft DR, Coleman ML, Li S, Robertson D, Sullivan T, Stewart CL, Olson MF. 2005. Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration. J Cell Biol 168: 245-255.
16. Dergham P, Ellezam B, Essagian C, Avedissian H, Lubell WD, McKerracher L. 2002. Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 22: 6570-6577.
17. Duggal N, Schmidt-Kastnet R, Hakim AM. 1997. Nestin expression in reactive astrocytes following focal cerebral ischemia in rats. Brain Res 768: 1-9.
18. Eddleston M, Mucke L. 1993. Molecular profile of reactive astrocytes-Implications for their role in neurologic disease. Neuroscience 54: 15-36.
19. Fawcett JW, Asher RA. 1999. The glial scar and central nervous system repair. Brain Res Bull 49: 377-391.
20. Fehlings MG, Theodore N, Harrop J, Maurais G, Kuntz C, Shaffrey CI, Kwon BK, Chapman J, Yee A, Tighe A, McKerracher L. 2011. A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. J Neurotrauma 28: 787-796.
21. Ferguson B, Matyszak MK, Esiri MM, Perry VH. 1997. Axonal damage in acute multiple sclerosis lesions. Brain 120: 393-399.
22. Fournier AE, Takizawa BT, Strittmatter SM. 2003. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 23: 1416-1423.
23. Frisen J, Johansson CB, Torok C, Risling M, Lendahl U. 1995. Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury. J Cell Biol 131: 453-464.
24. Fuentes EO, Leemhuis J, Stark GB, Lang EM. 2008 Rho kinase inhibitors Y27632 and H1152 augment neurite extension in the presence of cultured Schwann cells. J Brachial Plex Peripher Nerve Inj 3: 19.
25. John GR, Chen L, Rivieccio MA, Melendez-Vasquez CV, Hartley A, Brosnan CF. 2004. Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J Neurosci 24: 2837-2845
26. Kadoya K, Tsukada S, Lu P, Coppola G, Geschwind D, Filbin MT, Blesch A, Tuszynski MH. 2009. Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury. Neuron 64: 165-172.
27. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Schut D, Fehlings MG. 2010. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci 20: 1657-1676.
28. Kotter MR, Li WW, Zhao C, Franklin RJM. 2006. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26: 328-332.
29. Lord-Fontaine S, Yang F, Diep Q, Dergham P, Munzer S, Tremblay P, McKerracher L. 2008. Local inhibition of Rho signaling by cell-permeable recombinant protein BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury. J Neurotrauma 25: 1309-1322.
30. Lu P, Yang H, Jones LL, Filbin MT, Tuszynski MH. 2004. Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J. Neurosci 24: 6402-6409.
31. McGee AW, Strittmatter SM. 2003. The Nogo-66 receptor: Focusing myelin inhibition of axon regeneration. Trends Neurosci 26: 193-198.
32. Mimura F, Yamagishi S, Arimura N, Fujitani M, Kubo T, Kaibuchi K, Yamashita T. 2006. Myelin-associated glycoprotein inhibits microtubule assembly by a Rho-kinase-dependent mechanism. J Biol Chem. 281: 15970-15979.
33. Monnier PP, Sierra A, Schwab JM, Henke-Fahle S, Mueller BK. 2003. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol Cell Neurosci 22: 319-330.
34. Nash B, Thomson CE, Linington C, Athur A, McCLure JD, McBride MW, Barnett SC. 2011. Modulating astrocyte phenotype affects myelination and is negatively mediated by cxcl10. J Neurosci 31: 13028-13038.
35. Neumann H, Kotter MR, Franklin RJ. 2009. Debris clearance by microglia: An essential link between degeneration and regeneration. Brain 132: 288-295.
36. Nomura H, Kim H, Mothe A, Zahir T, Kulbatski I, Morshead CM, Shoichet MS, Tator CH. 2010. Endogenous radial glial cells support regenerating axons after spinal cord transection. Neuroreport 21: 871-876.
37. Oudega M, Xu XM. 2006. Schwann cell transplantation for repair of the adult spinal cord. J Neurotrauma 23: 453-467.
38. Pearse DD, Pereira FC, Marcillo AE, Bates M., Berrocal YA, Filbin MT, Bunge MB. 2004. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 10: 610-616.
39. Powell EM. Meiners S, DiProspero NA, Geller HM. 1997. Mechanism of astrocyte-directed neurite guidence. Cell Tissue Res 207: 385-393.
40. Ramaker GJ, Moolenaar WH. 1998. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid. Exp Cell Res 245: 252-262.
41. Reynolds BA, Weiss S. 1996. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175: 1-13.
42. Rudge JS, Silver J. 1990. Inhibition of neurite outgrowth on astroglial scars in vitro. J Neurosci 10: 594-3603.
43. Ruff CA, Fehlings MG. 2010. Neural stem cells in regenerative medicine: Bridging the gap. Panminerva Med 52: 125-147.
44. Sahai E, Olson MF. 2006. Purification of TAT-C3 exoenzyme. Meth Enzymol 406: 128-140.
45. Schmidt JT, Morgan P, Dowell N, Leu B. 2002. Myosin light chain phosphorylation and growth cone motility. J Neurobiol 52: 175-188.
46. Schnidt-Kastner R, Humpel C. 2002. Nestin expression persists in astrocytes of organotypic slice cultures from rat cortex. Int J Dev Neurosci 20: 29-38.
47. Shearer MV, Niclou SP, Brown D, Asher RA, Holtmaat AJGD, Levine JM, Verhaagen J, Fawcett JW. 2003. The astrocyte/meningeal cell interface is a barrier to neurite outgrowth which can be overcome by manipulation of inhibitory molecules or axonal signalling pathways. Mol Cell Neurosci 24: 913-925.
48. Silver J, Miller JH. 2004. Regeneration beyond the glial scar. Nat Rev Neurosci 5: 146-156.
49. Sommer I, Schachner M. 1981. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev Biol 83: 311-27.
50. Sørensen A, Moffat K, Thomson C, Barnett SC. 2008. Astrocytes, but not olfactory ensheathing cells or Schwann cells, promote myelination of CNS axons in vitro. Glia 56: 750-763.
51. Thomson CE, McCulloch M, Sorenson A, Barnett SC, Seed BV, Griffiths IR, McLaughlin M. 2008. Myelinated, synapsing cultures of murine spinal cord-validation as an in vitro model of the central nervous system. Eur J Neurosci 28: 1518-1535.
52. Tom VJ, Steinmetz MP, Miller JH, Doller CM, Silver J. 2004. Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J Neurosci 24: 6531-6539.
53. Tura A, Schuettauf F, Monnier PP, Bartz-Schmidt KU, Henke-Fahle S. 2005. Efficacy of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in the rodent retina. Invest Ophthalmol Vis Sci 50: 452-461.
54. Vahidi B, Park JW, Kim HJ, Jeon NL. 2008. Microfluidic-based strip assay for testing the effects of various surface-bound inhibitors in spinal cord injury. J Neurosci Methods 17: 188-196.
55. van den Berg M, Castellote JM, Mahillo-Fernandez I, de Pedro-Cuesta J. 2010. Incidence of spinal cord injury worldwide: A systematic review. Neuroepidemiology 34: 184-192.
56. Vega FM, Fruhwirth G, Ng T, Ridley AJ. 2011. Rho A and RhoC have distinct roles in migration and invasion by acting through different targets. J Cell Biol 193: 655-665.
57. Wanner IB, Deik A, Torres M, Rosendahl A, Neary JT, Lemmon VP, Bixby JL. 2008. A new in vitro model of the glial scar inhibits axon growth. Glia 56: 1691-1709.
58. Watanabe N, Kato T, Fujita A, Ishizaki T, Narumiya S. 1999. Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat Cell Biol 1: 136-143.
59. White RE, Jakeman LB. 2008 Don't fence me in: Harnessing the beneficial roles of astrocytes for spinal cord repair. Restor Neurol Neurosci 26: 197-214.
60. Yamada M, Ivanova A, Yamaguchi Y, Lees MB, Ikenaka K. 1999. Proteolipid protein gene product can be secreted and exhibit biological activity during early development. J. Neurosci 19: 2143-2151.
61. Yoo YM, Lee U, Kim YJ. 2005. Apoptosis and nestin expression in the cortex and cultured astrocytes following 6-OHDA administration. Neurosci Lett 382: 88-92.